A clinical trial of Siddha drugs M V kashayam (Internally) for the management and treatment of COVID 19
Phase 2
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/11/029289
- Lead Sponsor
- Arul Anandar College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Inclusion criteria
1. Patients with positive RT- PCR test
2. The age group of 15 yrs to 60 yrs.
3. Patients with mild and moderate symptoms of COVID 19.
4. Patients of both sex and willing to accept the treatment method.
Withdrawal Criteria
i) Intolerance to the drug and development of any serious adverse effect during a drug trial.
ii) Poor patient compliance & defaulters
iii) Patient is unwilling to continue the course of clinical Study.
iv) The occurrence of any other systemic illness.
Exclusion Criteria
i.RT- PCR negative patients
ii.Patients of less than 15 yrs and above 60 yrs of age.
iii.Pregnant and breastfeeding women.
iv.Patients with severe COVID 19 symptoms.
v.Allopathic Antiviral treatment patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The medicine for Prophylactic and treatment of COVID 19 based on RT-PCR negative, CRPTimepoint: 12 weeks (3 months)
- Secondary Outcome Measures
Name Time Method Get approved medicine for COVID 19Timepoint: 7 days to 14 days